Molecular Targets Program, Center for Cancer Research , National Cancer Institute , Frederick , Maryland 21702-1201 , United States.
School of Pharmaceutical Sciences , Wenzhou Medical University , Wenzhou , Zhejiang 325035 , People's Republic of China.
J Nat Prod. 2018 Jul 27;81(7):1666-1672. doi: 10.1021/acs.jnatprod.8b00343. Epub 2018 Jul 6.
Six new macrophilone-type pyrroloiminoquines were isolated and identified from an extract of the marine hydroid Macrorhynchia philippina. The proton-deficient and heteroatom-rich structures of macrophilones B-G (2-7) were elucidated by spectroscopic analysis and comparison of their data with those of the previously reported metabolite macrophilone A (1). Compounds 1-7 are the first pyrroloiminoquines to be reported from a hydroid. The macrophilones were shown to inhibit the enzymatic conjugation of SUMO to peptide substrates, and macrophilones A (1) and C (3) exhibit potent and selective cytotoxic properties in the NCI-60 anticancer screen. Bioinformatic analysis revealed a close association of the cytotoxicity profiles of 1 and 3 with two known B-Raf kinase inhibitory drugs. While compounds 1 and 3 showed no kinase inhibitory activity, they resulted in a dramatic decrease in cellular protein levels of selected components of the ERK signal cascade. As such, the chemical scaffold of the macrophilones could provide small-molecule therapeutic leads that target the ERK signal transduction pathway.
从菲律宾海葵 Macrorhynchia philippina 的提取物中分离鉴定了 6 种新的巨环内酯型吡咯并 iminoquinones。通过光谱分析和与先前报道的代谢产物巨环内酯 A(1)的数据比较,阐明了巨环内酯 B-G(2-7)的质子不足和杂原子丰富的结构。化合物 1-7 是首次从水螅中报道的吡咯并 iminoquinones。巨环内酯类物质被证明抑制 SUMO 与肽底物的酶促结合,并且巨环内酯 A(1)和 C(3)在 NCI-60 抗癌筛选中表现出强大且选择性的细胞毒性。生物信息学分析显示,1 和 3 的细胞毒性谱与两种已知的 B-Raf 激酶抑制药物密切相关。虽然化合物 1 和 3 没有激酶抑制活性,但它们导致 ERK 信号级联中选定成分的细胞蛋白水平显著下降。因此,巨环内酯的化学结构可以提供针对 ERK 信号转导途径的小分子治疗先导物。